Proteon Therapeutics
Waltham, US · Delaware corporation
Find your way into Proteon Therapeutics
198 people in our graph share verified history with the Proteon Therapeutics team — schools, employers, funds. One of them is your warm intro.
Quentin Clarkunlockedknows Dean Profis · together at University of Massachusetts Amherst (overlapped)
×6knows the team · via Northwestern University - Kellogg School of Management
knows the team · via Ring Therapeutics
×3knows the team · via Russell Reynolds Associates
knows the team · via Alnylam
Founders & leadership
FN
F. Nicholas FrananoFounder
TK
Tony KingsleyExecutive
SK
Steven K. Burke, M.D.Executive
TP
Timothy P. NoyesinPresident and CEO2006–2019
GA
George A. EldridgeExecutive
DP
Dean ProfisinSr. Director of Finance2014–2019He has experience in financial management across venture capital, private, and public company stages, including equity raises, debt offerings, and SEC compliance, and holds an MBA from the Kellogg Graduate School of Management and a CPA license.
MP
Matthew P. KowalskyNamed on SEC filing
PJ
Paul J. HastingsNamed on SEC filing
ES
E. Scott TonerNamed on SEC filing
SA
Scott A. CanuteNamed on SEC filing
Board
JG
John G. Freund, M.D.Board director
HB
Hubert Birner, Ph. D.Board director
Reported raises · per SEC filings
Form D private placements$55.9M disclosed across 3 rounds · 2013–2017
▶$22MraisedAug 2017 · 11 investors · BiotechnologyRule 506(b)
▶$22MraisedAug 2017 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew P. KowalskyExecutive Officer
- Tony KingsleyDirector
- John G. Freund, M.D.Director
- Steven K. Burke, M.D.Executive Officer
- Hubert Birner, Ph. D.Director
- Jonathan LeffDirector
- Paul J. HastingsDirector
- E. Scott TonerExecutive Officer
- Tim HainesDirector
- Timothy P. NoyesExecutive Officer, Director
- Scott A. CanuteDirector
- George A. EldridgeExecutive Officer
- Garen BohlinDirector
- Daniel P. GottliebExecutive Officer
- Offering amount
- $22M
- Amount sold
- $22M
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$29.6MraisedMay 2014 · 22 investors · BiotechnologyRule 506(b)
▶$29.6MraisedMay 2014 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel P. GottliebExecutive Officer
- Timothy NoyesExecutive Officer, Director
- Hubert BirnerDirector
- George EldridgeExecutive Officer
- John G. FreundDirector
- Steven K. BurkeExecutive Officer
- F. Nicholas FrananoDirector
- Todd FoleyDirector
- Tim HainesDirector
- Dmitry KobyzevDirector
- Gregory D. PhelpsDirector
- Brendan O'LearyDirector
- Offering amount
- $29.6M
- Amount sold
- $29.6M
- First sale
- May 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$4.3MraisedFeb 2014 · 17 investors · BiotechnologyRule 506(b)
▶$4.3MraisedFeb 2014 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stephen HoffmanDirector
- Gregory D. PhelpsDirector
- Dean ProfisExecutive Officer
- F. Nicholas FrananoDirector
- Hubert BirnerDirector
- Timothy NoyesExecutive Officer, Director
- Todd FoleyDirector
- Brendan O'LearyDirector
- Offering amount
- $4.3M
- Amount sold
- $4.3M
- First sale
- Sep 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Proteon Therapeutics?
- Proteon Therapeutics was founded by F. Nicholas Franano.
- How much funding has Proteon Therapeutics raised?
- Proteon Therapeutics has disclosed $55.9M raised across 3 rounds.
- Where is Proteon Therapeutics headquartered?
- Proteon Therapeutics is headquartered in Waltham, US.